[Elsevier] Efficacy and Safety of Azacitidine in Patients With RUNX1::RUNX1T1 Measurable Residual Disease-Positive Acute Myeloid Leukemia After Consolidation Therapy Who Did Not Undergo Allogeneic Hematopoietic Stem-Cell Transplantation

Kalyan@123 Post time 6 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-26 18:21
Reward10points

journalㄩClinical Lymphoma Myeloma and Leukemia

AuthorsㄩHuazhou Shi; Dapeng Peng; Nannan Qi; Yan Wang; Zhiyun Niu; Jingyu Zhang

Published dateㄩ2026-9-

DOIㄩ10.1016/j.clml.2026.09.006

PDF linkㄩhttps://www.sciencedirect.com/sc ... 152265026032921/pdf

Article linkㄩhttps://doi.org/10.1016/j.clml.2026.09.006

Article SourceㄩElsevier BV﹝


Remarkㄩplease provide the article pdf on urgent basis

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
cheawonx Post time 6 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    20


Daily Top Contributors

Return to the list